Abstract | BACKGROUND: We previously performed a multicenter prospective single-arm trial of 100 patients treated with Axium MicroFX Coils (ev3; Plymouth, Minnesota, USA), AMERICA: Axium MicroFX for Endovascular Repair of IntraCranial Aneurysm study. Initial angiographic and clinical outcomes were excellent. The final results are presented herein. METHODS: AMERICA is a multicenter, prospective single-arm trial evaluating the safety and efficacy of the ev3 Axium MicroFX coil system in 100 separate aneurysms between April 2010 and October 2012. Trial endpoints were 3-6 month angiographic occlusion and clinical status, as reported by treatment center. RESULTS: Mean follow-up was 157.9 days (median 153.5, range 1-445, SEM 9.3 days). At last follow-up imaging, 90.6% of all aneurysms, 90% of unruptured aneurysms, and 93.3% of ruptured aneurysms had Raymond grade I or II occlusion. Progression to further occlusion (lower Raymond occlusion grade) occurred in 29/85 aneurysms (34.1%). Aneurysm recurrence occurred in 11/85 aneurysms (12.9%). Ninety-nine per cent of patients treated electively and 68.7% of ruptured patients had a modified Rankin score of 0-2. Delayed adverse events (AEs), occurring after discharge and during the follow-up period, occurred in 10% of patients. In total, two AEs (one severe and one moderate) were potentially related to the device, thereby providing a 2% device-related AE rate. CONCLUSIONS: In this prospective, multicenter series of 100 aneurysms treated with Axium MicroFX PGLA (polyglycolic/ polylactic acid) coils, 3-6 month angiographic occlusion and clinical outcomes were excellent. This study suggests that Axium MicroFX PGLA coils are safe and effective in the treatment of intracranial aneurysms.
|
Authors | Kyle M Fargen, Spiros Blackburn, Eric M Deshaies, Jeffrey S Carpenter, Pascal Jabbour, William J Mack, Ansaar T Rai, Adnan H Siddiqui, Raymond D Turner, J Mocco |
Journal | Journal of neurointerventional surgery
(J Neurointerv Surg)
Vol. 7
Issue 1
Pg. 40-3
(Jan 2015)
ISSN: 1759-8486 [Electronic] England |
PMID | 24394153
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. |
Chemical References |
- Coated Materials, Biocompatible
- Polyesters
- Polymers
- Polyglycolic Acid
- Lactic Acid
- poly(lactide)
|
Topics |
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Coated Materials, Biocompatible
(adverse effects, therapeutic use)
- Embolization, Therapeutic
(adverse effects, instrumentation, methods)
- Endovascular Procedures
(adverse effects, instrumentation, methods)
- Female
- Follow-Up Studies
- Humans
- Intracranial Aneurysm
(diagnostic imaging, therapy)
- Lactic Acid
- Male
- Middle Aged
- Outcome Assessment, Health Care
- Polyesters
- Polyglycolic Acid
- Polymers
- Radiography
- Young Adult
|